Presubmission Regulatory Strategy For Medical Device Manufactures – A Cliniexperts Guide
When manufacturers talk about registering their medical devices, they get confused about where to start. Being a manufacturer, they have plenty of questions regarding the submission of their devices which remain unanswered. In this case, a well-defined global regulatory strategy is helpful for them as it helps them navigate complex requirements across multiple regions, ensuring compliance with diverse regulatory frameworks. As a seasoned service provider for regulatory, CliniExperts have seen plenty of cases where manufacturers don’t understand the basics of regulations. They think of regulations as obstacles instead of being the guiding path for them. In this article, we will discuss the Pre-Submission activities critical for manufacturer of medical devices and how CliniExperts can help navigate this crucial phase.
Pre-Submission

At this stage, manufacturers refine their regulatory strategy, ensure GMP readiness, implement QMS, and conduct preclinical testing to support submission. Proper preparation not only strengthens documentation but also reduces delays and optimizes approval timelines.
| Pre-Submission Activity | Purpose | Key Actions |
| Understanding Regulatory Requirements | Helps manufacturers align their devices with global regulations | Identify applicable standards (FDA, EU MDR, etc.), consult regulatory experts |
| Collaboration with Regulatory Service Providers | It mainly facilitates the interactions with regulatory bodies to ensure smooth compliance | Engage service providers like CliniExperts, conduct regulatory strategy discussions |
| Good Manufacturing Practices (GMP) Readiness | To ensure that facility and process compliance with quality standards | Audit manufacturing processes, implement ISO 13485-compliant QMS |
| Quality Management System (QMS) Implementation | Establishes structured documentation and risk management | Align with ISO 14971, maintain proper CAPA procedures |
| Preclinical Testing Preparation | Validates product safety, performance, and substantial equivalence | Conduct biocompatibility, electrical safety, and sterilization assessments |
| Regulatory Documentation Strengthening | Reduces risks of submission delays and ensures comprehensive records | Prepare technical files, perform gap analysis, optimize submission strategy |
Facility & GMP Readiness Audit:
The facility readiness based on GMP (Good manufacturing practices) is the most critical step. The manufacturing facility that complies with the regulatory requirements and standards is considered safe for manufacturing medical devices as they follow the guidelines set by regulatory bodies. Compliance to GMP is considered as the most crucial and basic step while defining the global regulatory strategy for regulations. GMP Audit and inspection of facility assess whether the manufacturing site can manufacture devices that will meet the safety and efficacy requirements of regulatory bodies. They mainly review the different aspects of medical devices such as calibration, training of personals, and sterilization processes.
Ensuring that documentation, such as Device Master Records (DMRs) and Design History Files (DHFs), is up to date can streamline regulatory submissions.
GMP guidelines for medical devices across different regulatory regions:
| Country/Region | Regulatory Body | GMP Framework | Key Requirements |
| United States | FDA | 21 CFR Part 820 also called (Quality System Regulation)  | Risk-based QMS, design controls, CAPA, production & process controls |
| European Union | EMA (EU MDR Compliance) | ISO 13485:2016 i | QMS alignment, post-market surveillance, clinical evaluation |
| Japan | PMDA (Pharmaceuticals and Medical Devices Agency) | Ministerial Order on GMP Standardsii | Manufacturing control, quality assurance, PIC/S GMP alignment |
| China | NMPA (National Medical Products Administration) | GMP for Medical Devices (Order No. 64)  | Facility inspections, risk-based quality management, post-market surveillance |
| Canada | Health Canada | Part C, Division 2 of the Food and Drug Regulationsiii | GMP inspections, QMS compliance, documentation integrity |
| Australia | TGA (Therapeutic Goods Administration) | Australian Regulatory Guidelines for Medical Devices (ARGMD)iv | Essential principles, conformity assessment, GMP clearance |
| United Kingdom | MHRA (Medicines and Healthcare products regulatory agency) | GMP Guidelines for Medical Devicesv | Compliance with EU GMP standards, risk-based inspections, QMS alignment |
QMS Review (ISO 13485)
QMS for medical device is a structured framework, that documents the policies, processes and procedures which are applied throughout the life cycle of a medical device. QMS is considered as the most critical step for manufacturers of medical device as it is the base of their most of the documents. The main goal of QMS is to ensure that the process runs efficiently while maintain the quality. It also ensures that product is safe, compliant and maintain quality as per the ISO 13485. QMS oversees each step during product development. From design control and risk management to supplier evaluation and post-market surveillance, every step needs to be aligned with QMS and most importantly it falls upon the duty of manufacturer. QMS in medical device act as a guarantor that there were low errors in products and promotes the safety and quality of the marketed product.
Main processes of QMS specifically for medical device manufacturers involves document control, change control, employee training, audit management, CAPA, supplier management, risk management, and complaint handling. Remember recalls are costly, fine from governments are hefty but most importantly non-complaint ruins the reputation of the company. All it can be avoided with a robust QMS plan in place from the beginning which can be achieved by the help of regulatory service provider like CliniExperts.
| Region | Regulatory Authority | QMS Requirements |
| United States | FDA (21 CFR Part 820) | Quality System Regulation (QSR) for medical devices |
| European Union | EU MDR & IVDR | Requires compliance with ISO 13485 and risk management under ISO 14971 |
| Canada | Health Canada | Mandatory MDSAP certification for medical device manufacturers |
| India | CDSCO | ISO 13485 certification for medical device registration is required. |
| China | NMPA | Enforces Good Manufacturing Practices (GMP) and ISO 13485 compliance |
| Australia | TGA | Follows ISO 13485 and EU MDR-aligned regulations |
Risk Management Review
Being a manufacturer it’s very critical to define and mention the risks associated with the use of your device. Risks do not associate after their device has been marketed but risk remediation starts from the development stage of the device so that when device gets ready the benefit to risk ratio is high. Risk management review involves Identification, awareness, control, and prevention of failures that could present risks to patients using medical device are all part of risk management. It is the manufacturers’ duty to identify any possible design-related dangers in both typical and challenging conditions. It is important to consider both normal and defective circumstances while computing the risks related to the hazards, including those caused by user mistake. Any risk that is deemed undesirable should be appropriately mitigated to bring it down to acceptable levels.
| Topic | Details |
| Standard Definition | The ISO 14971-Medical devices application of risk management is the medical devices standard for risk management. |
| Scope | It covers standards for risk management across a medical device’s whole life cycle, from initial conceptualization to ultimate decommissioning. |
| Market Impact | The doors to most of the world’s largest medical device markets would be closed if risk management and ISO 14971 standards weren’t met. |
| Purpose | ISO 14971 provides specifications for a medical device risk management approach. |
| Current Version | The ISO 14971:2019 version is the most recent. |
| Industry Significance | ISO 14971 is cited in many highly significant standards in the medical device sector. |
| Implementation Advice | Therefore, putting this standard into practice is highly advised. |
Preclinical Testing
Preclinical testing involves evaluating medical devices based on many criteria to determine the safety and effectiveness of the device being marketed. A medical device’s overall biocompatibility is tested (e.g., in accordance with established standards like ISO 10993), component testing (e.g., using ASTM methods). The appropriate selection and competence of the raw materials used in the device’s construction, and final design validation testing are all examples of endpoints that are typically used in pre-clinical testing to evaluate a device’s safety. It’s critical that manufactures recognise the main goals of preclinical testing. Remember to consider the materials used for manufacturing your device when you approach preclinical testing for medical devices. Does your device use materials that have never been used in a predicate device to test on humans?
Verify that each material has enough mutagenicity and genotoxicity datasets, which are defined as the capacity to produce toxicity or mutations. It is time to consult different standards to ascertain which material safety tests are required in the absence of a substantial body of clinical evidence.
Testing component for medical device pre-clinical testing:
| Testing Category | Purpose | Standards/Notes |
| Biocompatibility Testing | Evaluates how the device interacts with biological systems. | Follow ISO 10993 standards. |
| Mechanical & Functional Testing | Assesses device durability, reliability, and performance in simulated use. | Includes fatigue, tensile, and load tests. |
| Toxicology Studies | It helps in determining any possible adverse effects of the materials being used. | May involve cytotoxicity and genotoxicity tests. |
| Sterilization & Packaging Validation | Verifies the integrity of the package and sterility throughout the shelf life. | Includes ISO 11135, 11607 compliances. |
| Animal Studies (if applicable) | Observes physiological responses in live organisms. | Required when in vitro tests are insufficient. |
Conclusion
Manufacturers often don’t understand the importance of pre submission preparation for registering their devices. While it can be overwhelming, but it is also very important to be prepared for submission from the start to avoid delays and fines. In pre submission manufacturer should mainly focus on GMP readiness, Audits, Risk management along with testing required as these are the basics of documentation across all regions for regulatory submissions.
Most of the manufacturers see regulations as barriers but they not only safeguard the patient population but also them. With a proactive manufacturer can register their device without any hurdle in a timely manner.
How CliniExperts can help:
With years of experience in supporting manufacturers to register their device CliniExperts has gained extensive knowledge of the Pre submission activities required for medical device manufacturers.
From helping manufacturers to GMP readiness, audit, QMS implementation to testing requirement CliniExpert got you covered. Using extensive experience, we help manufacturers to identify compliance shortcomings and assist manufacturers in addressing these issues before they become regulatory queries.
Our primary objective is to ensure that products enter the market with complete compliance, efficiently and within the anticipated period.
divya choudhary
CliniExperts Services Pvt. Ltd.
Contact us
Please feel free to talk to us if you have any questions. We endeavour to answer within 24 hours.